Business
Asahi Kasei Pharma to Relocate Global R&D Hub to Shonan iPark
TOKYO, December 22, 2025--Asahi Kasei Pharma Corporation has announced plans to relocate its R&D hub from Izunokuni City, Shizuoka Prefecture to Shonan Health Innovation Park.
About this update from Asahi Kasei Corporation
[{"type":"image","alt":"Asahi Kasei Pharma Shonan Health Innovation Park (Shonan iPark)","displaySize":"","headline":null,"caption":"Asahi Kasei Pharma Shonan Health Innovation Park (Shonan iPark)","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":320,"url":"https://media.zenfs.com/en/business-wire.com/618fd8582ebb798271cd49c877dd5e97"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/RLrg.WcsNWLikezGTqme0g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY0MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/618fd8582ebb798271cd49c877dd5e97","width":480,"height":320}},"lazy":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":4999,"height":683,"url":"https://media.zenfs.com/en/business-wire.com/32d364dd8b5b42fca3cdb002d09192c8"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/pxPgmefmGyaRTjW.nw3xqQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTEzMTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/32d364dd8b5b42fca3cdb002d09192c8","width":960,"height":131},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/3ioY0GbMnY8wquRCkCMCDQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0zMjg7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/32d364dd8b5b42fca3cdb002d09192c8","width":1200,"height":164}}},{"type":"text","content":"Advancing Open Innovation in Drug Discovery and Facilitating Reliable Market Introduction","length":89,"tagName":"p","attribs":{}},{"type":"text","content":"TOKYO, December 22, 2025--(BUSINESS WIRE)--Asahi Kasei Pharma Corporation has announced plans to relocate its R&D hub from Izunokuni City, Shizuoka Prefecture (Ohito) to Shonan Health Innovation Park (Shonan iPark) in January 2027. The move will strengthen the company’s global R&D capabilities for its pharmaceuticals business and accelerate open innovation through collaboration with external partners to advance drug discovery.","length":438,"tagName":"p"},{"type":"text","content":"Asahi Kasei Pharma has developed strong capabilities in proprietary drug discovery, in addition to its clinical development expertise. In recent years, the company has shifted its focus toward discovering and commercializing new drugs through open innovation leveraging external partnerships and collaborations. This approach is expected to enhance develop...